← Back to MRVI

Maravai LifeSciences Holdings, Inc. - Class A common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 08/05/2026Sep 2025Filed 07/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 08/05/2026Sep 2024Filed 07/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 12/05/2025
$51$66$42$47$47$69$69$64
−$12−$3.7−$26−$40−$30−$97−$9.8−$12
−$0.08−$0.02−$0.18−$0.27−$0.21−$0.68−$0.07−$0.09
148146145144143142136132

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.